Assessing coronary artery disease severity using the TyG index in patients with LDL-C < 2.6 mmol/l

使用 TyG 指数评估 LDL-C < 2.6 mmol/l 患者的冠状动脉疾病严重程度

阅读:1

Abstract

BACKGROUND: Determining the triglyceride‒glucose (TyG) index’s relationship to coronary lesions in patients with low-density lipoprotein cholesterol (LDL-C) targes will inform precision management of cardiovascular disease. METHODS: This retrospective cohort included 821 enrolled patients with LDL-C levels < 2.6 mmol/L who underwent coronary angiography at the Department of Cardiology, Tianjin Medical University General Hospital from January 2016 to February 2024. Participants were stratified by coronary heart disease (CHD) diagnosis, with subgroup analyses based on the number of vessels with coronary lesions and the Gensini score. Demographic and clinical data were collected, and the TyG index was calculated. Multiple statistical methods were employed to evaluate associations between variables and coronary lesion severity. RESULTS: Among the 821 enrolled patients, 644 were diagnosed with CHD, and 177 were not. An elevated TyG index was an independent CHD risk factor and was directly correlated with progressive coronary stenosis. Patients in the high-TyG subgroup presented more severe metabolic abnormalities and a higher CHD risk. The combination of the TyG index and glycated haemoglobin (HbA1c) was more strongly associated with CHD than either marker alone. HbA1c fully mediated the association between the TyG index and both CHD and lesion severity. The TyG index showed a stronger correlation with CHD in subgroup analyses, particularly among CHD patients not receiving lipid-lowering drugs and those wuth HbA1c levels < 6.5%. CONCLUSION: In individuals with LDL-C levels less than 2.6mmol/L, the TyG index remains independently associated with both the risk of CHD and the severity of coronary lesions. Integrating TyG and HbA1c optimizes risk stratification. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12944-025-02691-7.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。